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Abstract
ATP is a cotransmitter with classical transmitters in most nerves in the peripheral nervous system
and central nervous system, although the proportions vary between species and tissues and in
different developmental, physiological and pathophysiological conditions. ATP is released together
with noradrenaline and neuropeptide Y from sympathetic nerves. It is released as a cotransmitter
with acetylcholine from parasympathetic nerves supplying the bladder, developing skeletal
neuromuscular junctions and some neurons in the brain. It is also released with nitric oxide and
vasoactive intestinal polypeptide from non-adrenergic inhibitory enteric nerves, with glutamate from
primary afferent sensory nerves and in the hypothalamus, and with dopamine and 5-hydroxy-
tryptamine from some neurons in the central nervous system. Cotransmission offers subtle, local
variations in neurotransmission and neuromodulation mechanisms.
Introduction and context
The idea that neurons can synthesize, store, and release
only a single substance became known as ‘Dale’s
principle’, although Dale never explicitly suggested this;
rather, he speculated that the same neurotransmitter
would be stored and released from all the terminals of
a single sensory neuron. However, there were hints in
the literature that the one nerve/one transmitter
principle might not be universally true and this led to
my commentary introducing the cotransmitter hypoth-
esis in 1976 [1].
There isa substantial bodyofevidencetoshowthatATP is
a cotransmitter with classical transmitters in most nerves
in the peripheral nervous system and central nervous
system (CNS), although the proportions vary between
tissues and species and in different developmental,
physiological and pathophysiological circumstances
[2-4]. There was early evidence that ATP was released
together with acetylcholine(ACh) fromcholinergic nerves
in various tissues – for example, the electric organ of
elasmobranch fish, frog neuromuscular junction and
phrenic nerve endings in rat diaphragm [5]. However, it
was not recognized at the time as a cotransmitter, but was
considered rather as a molecule involved in the vesicular
uptake and storage of the neurotransmitter ACh. Later it
was shown that in neuromuscular junction early devel-
opment, released ATP acted on P2X receptor ion channels
as a genuine cotransmitter with ACh acting on nicotinic
receptors, while in mature animals ATP no longer acted as
a cotransmitter, but rather as a modulator at pre- and
postjunctional sites [6].
ATP was first shown to be released from sympathetic
nerves supplying the guinea-pig taenia coli [7]. Soon
after, the possibility that ATP might be co-released with
noradrenaline (NA) from the hypogastric nerve to the
guinea-pig seminal vesicle was raised [8], and that the
substantial residual non-adrenergic, non-cholinergic
(NANC) responses of cat nictitating membrane follow-
ing depletion of NA by reserpine might be due to the
release of ATP from sympathetic nerves [9]. The most
extensive evidence for sympathetic cotransmission came
from studies of the vas deferens, initially by Dave
Westfall and colleagues [10]. Sympathetic purinergic
cotransmission has also been clearly demonstrated in
many blood vessels, although the proportion of NA:ATP
is extremely variable in different vessels [2].
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utilise ACh and ATP as cotransmitters, in variable
proportions in different species [11,12] and, by analogy
with sympathetic nerves, ATP acts through P2X iono-
tropic receptors, whereas the slow component of the
response is mediated by a metabotropic muscarinic
receptor. There is also evidence to suggest that there is
parasympathetic purinergic cotransmission to resistance
vessels in the heart and airways.
The early work of Pamela Holton [13] showing ATP
release during antidromic stimulation of sensory collat-
erals taken together with the evidence for glutamate in
primary afferent sensory neurons suggests that ATP and
glutamate may be cotransmitters. Calcitonin gene-
related peptide and substance P are well established as
coexisting in sensory-motor nerves and, in some
subpopulations, ATP is also likely to be a cotransmitter
[14]. Concurrent release of ATP and substance P from
guinea-pig trigeminal ganglionic neurons in vivo has
been described [15].
A subpopulation of intramural enteric nerves provides
NANC inhibitory innervation of gut smooth muscle.
Three major cotransmitters are released from these
nerves: ATP producing fast inhibitory junction poten-
tials; nitric oxide also producing inhibitory junction
potentials, but with a slower time course; and vasoactive
intestinal polypeptide producing slow tonic relaxations
[16]. The proportions of these three transmitters vary
considerably in different regions of the gut and in
different species [17]. Purinergic inputs of myenteric
origin come from neurons utilising ACh and ATP as
cotransmitters in presynaptic fibres. In the heart,
subpopulations of intrinsic nerves in the atrial and
intra-atrial septum have been shown to contain ATP
as well as nitric oxide, neuropeptide Y, ACh and
5-hydroxytryptamine [18].
Major recent advances
The spectrum of physiological signalling variations
offered by cotransmission has been discussed more
recently [19]. For example, ATP released as a cotrans-
mitter can act as a prejunctional modulator of trans-
mitter release or as a postjunctional modulator,
synergistically enhancing the action of the cotransmitter.
Evidence for purinergic cotransmission in the CNS has
lagged behind that presented for purinergic cotransmis-
sion in the periphery. However, in the past few years
several such studies have been reported [20].
Release of ATP from synaptosomal preparations and
slices from discrete areas of the rat and guinea-pig
brain, including cortex, hypothalamus, medulla, and
habenula, has been measured. Earlier papers reported
that in cortical synaptosomes, a proportion of the ATP
appeared to be co-released with ACh, and a smaller
proportion with NA. There is also evidence for
co-release of ATP with catecholamines from neurons
in the hypothalamus and locus coeruleus [21].
Purinergic and adrenergic agonist synergism for vaso-
pressin and oxytocin release from hypothalamic
supraoptic neurons is consistent with ATP cotransmis-
sion in the hypothalamus [22].
Co-release of ATP with g-aminobutyric acid (GABA) has
been demonstrated in the rabbit retina and in dorsal
horn and lateral hypothalamic neurons [23]. P2X and
GABA receptors are also colocalised in subpopulations of
rat postnatal dorsal root ganglion neurons and their
central terminals laminae I-III. The intracellular loop of
GABAB subunits and the carboxy-terminal domain of
P2X . 2/P2X3 receptors are necessary for cross-talk between
ATP and GABA-gated channels [24]. There is evidence for
co-release of ATP with glutamate in the hippocampus
[25] as well as widespread and pronounced modulatory
effects of ATP on glutamatergic mechanisms. A recent
study has shown that in central neuronal terminals, ATP
is primarily stored and released from a distinct pool of
vesicles and that the release of ATP is not synchronized
with the cotransmitters GABA or glutamate [26].
Colocalisation of functional nicotinic and ionotropic
nucleotide receptors has also been identified in isolated
cholinergic synaptic terminals in midbrain, and interac-
tions between P2X2 and both a3b4 and a3b2 nicotinic
receptor channels have been shown in oocyte expression
studies [27].
There is indirect evidence supporting the possibility that
dopamine and ATP are cotransmitters in the CNS [28].
After cerebellar lesions in rats producing axotomy of
mossy and climbing fibre systems, nitrergic and
purinergic systems were activated with similar time
courses on pre-cerebellar stations [29]. It has been
speculated that postsynaptic selection of co-released
fast transmitters is used in the CNS to increase the
diversity of individual neuronal outputs and achieve
target-specific signalling in mixed inhibitory networks
[30].
There have been significant recent advances in the
development of sensitive assays for real-time assessment
of ATP release from individual cells (for example, see
[31,32]).
There has also been much emphasis recently on neuron-
glial interactions, including co-release of transmitters
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neurons [33,34].
Future directions
One of the questions still to be resolved concerns the
physiological roles of the many neuropeptides coloca-
lised with small molecule neurotransmitters in nerves.
This is particularly so in the enteric nervous system,
where careful immunohistochemical studies of the
’chemical coding’ of different populations of enteric
nerves showed that some neurons contain up to five
neuropeptides. For example, Dogiel type 1 neurons
contain bombesin, vasoactive intestinal polypeptide,
cholecystokinin, galanin and enkephalin, as well as its
primary transmitter ACh [35]. Some of the released
peptides appear to play neuromodulatory roles, others
long-term (trophic) roles, but for others their roles
remain a mystery.
There are well-established examples in the periphery (for
example, sympathetic cotransmission to the vas defe-
rens) where cotransmitters have synergistic postjunc-
tional actions [36]. However, few studies of the
synergistic actions of cotransmitters in the CNS have
been carried out. For example, it would be interesting to
see if ATP potentiates the long-term potentiation action
of glutamate on hippocampal neurons and the responses
of NA on hypothalamic neurons.
Finally, although the drug evaluation authorities have
always focused on single therapeutic agents, perhaps the
presence of cotransmitters will encourage the develop-
ment of multiple therapeutic agents for some conditions.
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